Critical Care Devices Market – By Product, By Application, By End Use – Global Forecast, 2025 to 2034

Critical Care Devices Market Size

The global critical care devices market size was valued at around USD 60.1 billion in 2024 and is estimated to grow at 5.5% CAGR from 2025 to 2034. Critical care devices are specialized medical equipment used to support and monitor patients in life-threatening situations, typically in intensive care units (ICUs).
 

These devices are crucial for managing severe health conditions that require continuous monitoring, rapid responses, and advanced medical interventions. Key types include ventilators for respiratory support, infusion pumps for precise medication delivery, patient monitors for vital sign tracking, defibrillators, which was valued at USD 11 billion in 2022, for cardiac emergencies, and dialysis machines for renal failure management.
 

The increasing prevalence of chronic conditions such as cardiovascular disease, respiratory illnesses, and diabetes is leading to a higher demand for critical care interventions. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Additionally, acute conditions, including infections and trauma, are driving the need for devices like ventilators, defibrillators, and infusion pumps to manage severe cases.
 

According to the Centers for Disease Control and Prevention (CDC), over 1.7 million adults in the U.S. develop sepsis each year, and at least 350,000 of these cases result in death. This rising burden of chronic and acute conditions underscores the growing importance of critical care devices in healthcare systems worldwide.
 

Moreover, the market is likely to be stimulated by an increasing number of product launches, mergers and acquisitions, collaborations, and regional expansions by industry players. For instance, in September 2024, BD, a global leader in medical technology, announced the completion of its acquisition of Edwards Lifesciences' Critical Care product group, renamed as BD Advanced Patient Monitoring. This new division strengthened BD’s portfolio of smart, connected care solutions with advanced monitoring technologies, AI-enabled clinical decision tools, and a robust innovation pipeline. Such initiatives are anticipated to drive significant growth in the market by enhancing innovation, expanding access to advanced monitoring solutions, and increasing competition.
 

Critical Care Devices Market Trends

• Artificial intelligence (AI) and machine learning are being integrated into critical care devices, including ventilators, patient monitors, and infusion pumps. This integration aims to improve clinical decision-making and predictive analytics.
   
• These technologies enable real-time patient monitoring, early detection of health deterioration, and automated device adjustments, leading to improved response times and outcomes in critical care environments.
   
• Additionally, remote monitoring and tele-ICU solutions have grown in popularity, particularly following the COVID-19 pandemic, which emphasized the need for remote critical care capabilities.
   
• These technologies allow healthcare professionals to monitor ICU patients remotely, reducing the workload on on-site staff and enhancing patient care. This trend is particularly significant in regions with limited healthcare access or under-resourced ICUs.
   

Critical Care Devices Market Analysis

Based on product, the market is segmented into defibrillators, multiparameter monitoring devices, ECG devices, hemodialysis machines, infusion pumps, ventilators, feeding tubes, anesthesia monitors, CRRT machines, and other products. The defibrillators segment dominated the market with the largest revenue share of 22.6% in 2024.
 

• The growing elderly population, more susceptible to cardiac issues, is another significant driver. For instance, the World Health Organization (WHO) reports that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%.
   
• As the global population ages, the demand for defibrillators to manage age-related heart conditions increases, particularly in regions experiencing rapid demographic shifts toward older populations. This demographic shift is expected to lead to a substantial increase in the prevalence of cardiovascular diseases, potentially driving up the demand for defibrillators in both clinical and public settings.
   
• Additionally, governments and healthcare organizations are investing in public access defibrillation (PAD) programs, placing automated external defibrillators (AEDs) in accessible public locations such as airports, schools, and sports facilities.
   
• Increased awareness of AEDs' life-saving potential and regulatory mandates for their installation in public places in some countries are expanding the market. This trend is particularly prominent in North America and Europe, where PAD programs are widely implemented.
   

Based on application, the critical care devices market is segmented into renal care, cardiology, neurology, and other applications. The cardiology segment dominated the market with the largest revenue share of 35.8% in 2024.
 

• Cardiovascular diseases (CVDs), particularly heart attacks, heart failure, and other cardiac emergencies, remain the leading cause of death globally. For instance, according to the World Heart Federation, global deaths from cardiovascular disease (CVD) increased from 12.1 million in 1990 to 20.5 million in 2021.
   
• This prevalence has increased demand for critical care devices such as effective monitoring and life-support systems in cardiology settings, especially in intensive care units (ICUs) and emergency departments.
   
• Additionally, the demand for minimally invasive and non-invasive cardiac procedures has grown, driving the need for advanced monitoring devices that can handle these procedures with high precision and minimal patient discomfort.
   
• Cardiac catheterization, electrophysiology studies, and ablation procedures often require critical monitoring, increasing demand for specialized critical care cardiology equipment.
   

Based on end use, the critical care devices market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and other end-users. The hospitals segment dominated the market with the largest revenue share of 43.3% in 2024.
 

• Healthcare technology innovations, such as advanced patient monitoring systems, AI-powered decision support tools, and connected devices, are improving critical care efficiency and effectiveness.
   
• Hospitals are increasingly implementing these technologies to facilitate real-time data collection, analysis, and decision-making, leading to enhanced patient outcomes and operational efficiency in intensive care units.
   
• Additionally, the COVID-19 pandemic triggered a significant increase in demand for critical care devices, especially ventilators and oxygen therapy equipment, to manage growing hospital admissions and complicated respiratory complications.
   
• For instance, according to the National Institutes of Health, intensive care unit occupancy rates rose by 67.8% during periods of high COVID-19 admissions. This surge prompted hospitals to invest in more robust and expanded critical care infrastructure, resulting in a sustained demand for these devices.
   

• The U.S. Critical care devices market is projected to grow significantly, reaching USD 34.4 billion by 2034.
   
• The significant presence of market players in the U.S. is poised to drive substantial market growth, as companies continue to innovate and expand their offerings. For example, GE HealthCare’s acquisition of Intelligent Ultrasound Group’s AI software enhances its ultrasound portfolio, improving both workflow efficiency and usability.
   
• This move is expected to strengthen GE HealthCare's position in the U.S. market, where demand for advanced critical care technologies continues to rise. As such, ongoing investments and acquisitions are likely to fuel continued growth in the U.S. critical care device sector, enhancing both technological capabilities and patient care outcomes.
   

The critical care devices market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The United Kingdom is experiencing an increased demand for critical care devices due to the rising prevalence of chronic diseases, including cardiovascular diseases, respiratory disorders, and diabetes. For instance, according to Diabetes UK, it is estimated that around 5.6 million individuals in the UK were affected by diabetes in 2023.
   
• Additionally, the aging population, especially the elderly, is more vulnerable to these conditions, resulting in higher hospitalization rates and an increased need for intensive care equipment.
   
• This demographic shift has led to a greater requirement for critical care devices such as ventilators and patient monitoring systems. As a result, healthcare providers are investing in advanced critical care equipment to meet the growing demand and improve patient outcomes in the region.
   

Japan critical care devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• In 2023, the average life expectancy in Japan was 87.14 years for women and 81.09 years for men, ranking among the highest globally according to the World Health Organization (WHO). This longevity has led to a rapidly aging population, with 29.1% of Japanese citizens aged 65 or older in 2023, as reported by the BBC.
   
• As older adults are at higher risk of chronic and critical health conditions, such as cardiovascular diseases, respiratory disorders, and stroke, the demand for critical care devices to ensure intensive monitoring and life-support is increasing. This demographic shift is likely to continue driving the growth of the market in Japan.
   

The critical care devices market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The increasing prevalence of lifestyle-related diseases, including cardiovascular diseases, diabetes, and respiratory illnesses, has led to a higher demand for critical care devices.
   
• For instance, according to the National Institutes of Health, acute lower respiratory tract infection affects over 15% of Saudi Arabia's population each year. This trend has driven the need for advanced monitoring devices, ventilators, and life-support systems in healthcare facilities across the country.
   

Critical Care Devices Market Share

The market is competitive, featuring both major global companies and numerous smaller firms. A key strategy for participants is investing in the development of advanced critical care devices technologies, such as AI-enabled devices, remote patient monitoring, smart ventilators, and wearable critical care devices, to enhance accuracy and efficiency. Strategic partnerships with research institutions and healthcare providers are crucial for integrating new technologies and expanding distribution, enabling companies to address the rising demand for critical care devices. Regulatory support and streamlined approval processes further drive innovation and market entry, solidifying the position of firms within the growing market.
 

Critical Care Devices Market Companies

Some of the eminent market participants operating in the critical care devices industry include:

• Air Liquide Medical Systems India
• Asahi Kasei Corporation
• B. Braun Melsungen
• Baxter
• Becton, Dickinson and Company
• Boston Scientific corporation
• Cardinal Health
• Drägerwerk
• Fresenius Medical Care
• GE Healthcare
• Getinge
• Hamilton Medical
• ICU Medical
• Koninklijke Philips
• Medtronic
   

Critical Care Devices Industry News:

• In September 2024, Medtronic launched the VitalFlow, an all-in-one extracorporeal membrane oxygenation (ECMO) system, designed to offer a user-friendly experience. The company aimed to create a simple and intuitive device that would assist clinicians by streamlining the ECMO process, making it easier to operate. This launch strengthened Medtronic's position in the critical care market by providing healthcare professionals with advanced, easy-to-use technology.
   
• In January 2022, ICU Medical Inc. announced the completion of its acquisition of Smiths Medical from Smiths Group plc. Smiths Medical's business includes syringe and ambulatory infusion devices, vascular access, and vital care products. This acquisition strengthened ICU Medical’s portfolio, expanding its offerings in critical care and infusion therapy.
   

The critical care devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and volume in Units from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Defibrillators
• Multiparameter monitoring devices
• ECG devices
• Hemodialysis machines
• Infusion pumps
• Ventilators
• Feeding tubes
• Anesthesia monitors
• CRRT machines
• Other products

Market, By Application

• Renal care
• Cardiology
• Neurology
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Poland
  • Austria
  • Denmark
  • Switzerland
  • Netherlands
  • Czech Republic
  • Sweden 
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Vietnam 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Iran